People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CoreMap, Inc. | — | Biotechnology | Series B | $39.8M | $47.3M | 2024 |
| Regenerative Bioelectronics Inc. | — | Other | Seed | $1.2M | $7.9M | 2023 |
Sarah O Kalil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sarah O Kalil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adam Rothstein | 1 | 4 |
| Allen Kamer | 1 | 3 |
| Sarah Kalil | 1 | 2 |
| Adam O Rothstein | 1 | 1 |
| Peter Spector | 1 | 1 |
| Allen O Kamer | 1 | 1 |
| RONNY GINOR | 1 | 1 |
| Peter S Spector | 1 | 1 |
| William S Gruber | 1 | 1 |
| David N. Constantine | 1 | 1 |
| MARIO I. ROMERO-ORTEGA | 1 | 1 |
| Peter O Spector | 1 | 1 |
| Anilkumar I. ACHYUTA | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.